Ambica Agarbathies Schedules November 5 Q2 FY27 Board Meeting

Ambica Agarbathies Aroma & Industries Limited has scheduled a board meeting on November 5, 2026, to consider unaudited Q2 FY27 and half-year results, following Q1 FY27 net sales of ₹24.65 crore and net profit of ₹1.11 crore.

What will Ambica Agarbathies consider at the November 5 meeting?

Ambica Agarbathies will consider and approve its unaudited financial results for the second quarter and first half of FY27 ended September 30, 2026. The company informed BSE Limited and the National Stock Exchange of India Limited about the board meeting through a disclosure dated October 31, 2026.

The meeting covers the July-September 2026 quarter, commonly referred to as Q2 FY27, as well as the six-month period from April through September 2026. The filing is a board-meeting intimation, not a release of the quarter's financial results. Revenue, profit, margins and other reported financial details for Q2 will become available only after the board considers the results and the company files them with the exchanges.

When is Ambica Agarbathies expected to publish Q2 FY27 results?

Ambica Agarbathies has set November 5, 2026, as the date on which its board will consider the Q2 FY27 results. The scheduled meeting falls 36 days after the September 30 quarter-end, based on the results-date data provided.

The company had historically published results between 41 and 60 days after quarter-end across the last eight quarters on file. The current timetable is therefore earlier than that historical range. Indian listed companies are required to publish September-quarter results within 45 days of the quarter-end, placing November 14, 2026, as the stated outer deadline for the September 2026 quarter.

Before the board-meeting filing, the Q2 FY27 results date had not been confirmed. The October 31 disclosure now provides the formal schedule for the board's consideration of the financial statements. Investors should distinguish between the board-meeting date and the actual exchange filing, which will contain the approved unaudited numbers and notes to accounts.

How did Ambica Agarbathies perform in Q1 FY27?

Ambica Agarbathies reported net sales of ₹24.65 crore in the quarter ended June 2026, down 18.2% from ₹30.14 crore in the year-earlier quarter and up from ₹22.27 crore in the March 2026 quarter. The company reported net profit of ₹1.11 crore, 3.0% lower year on year, according to the quarterly snapshot provided.

The company's standalone total income from operations was reported at ₹26.63 crore for Q1 FY27, compared with ₹31.88 crore in the corresponding prior-year quarter and ₹25.66 crore in the preceding March 2026 quarter. The difference between net sales and total income from operations reflects the separate reporting lines cited in the available disclosures.

Operating profit for the June 2026 quarter was ₹3.16 crore, against ₹1.97 crore in March 2026. Operating profit margin improved to 12.82%, compared with 8.85% in the preceding quarter and 10.25% in June 2025. Basic and diluted earnings per share for Q1 FY27 were ₹0.64 each.

Which figures provide the comparison base for Q2 FY27?

Ambica Agarbathies' September 2025 quarter provides the direct year-on-year comparison base for the forthcoming Q2 FY27 results. Net sales in Q2 FY26 were ₹34.63 crore and net profit was ₹0.93 crore, according to the available quarterly data.

The quarterly series shows that sales have varied materially in recent periods. Net sales rose to ₹54.04 crore in the December 2025 quarter, before declining to ₹22.27 crore in March 2026 and recovering to ₹24.65 crore in June 2026. These figures provide context for assessing the Q2 release, but they do not indicate what the September 2026 numbers will be.

The Agarbathies division remained the main contributor in Q1 FY27, generating segment revenue of ₹18.53 crore and pre-tax profit of ₹2.70 crore. This segment-level data will be relevant when the company releases its September-quarter accounts, particularly if it provides comparable segment disclosures.

Why does the board meeting matter to investors?

The meeting matters because it establishes the official point at which Ambica Agarbathies' Q2 FY27 financial performance will be considered by its board. The exchange filing following the meeting will allow investors to compare the September-quarter outcome with the ₹34.63 crore sales and ₹0.93 crore net-profit base reported a year earlier.

The June-quarter figures also provide a recent operating reference. While sales were lower year on year, the company reported a 12.82% operating margin and ₹1.11 crore net profit. The Q2 filing will show whether the company maintained, improved or reduced those reported profitability levels during the first half of FY27.

Ambica Agarbathies has also recently made corporate disclosures, including an October 7 quarterly financial-results and operating-metrics update and an October 5 filing on strategic growth initiatives and governance matters. Separately, a recent announcement stated that FY26 profit after tax rose to ₹3.45 crore and that the board approved a ₹2.04 crore preferential issue. The current board-meeting notice, however, is specifically concerned with approval of the September-quarter and half-year unaudited results.

Conclusion

Ambica Agarbathies has formally scheduled its November 5 board meeting to consider Q2 FY27 and first-half unaudited results. The upcoming filing will be assessed against the September 2025 base of ₹34.63 crore in net sales and ₹0.93 crore in net profit, as well as the June 2026 quarter's ₹24.65 crore net sales, ₹1.11 crore net profit and 12.82% operating margin.

Investors should watch for the approved exchange filing after the meeting, including revenue, profitability, earnings per share, segment details and half-year figures. The company has not provided a verified Q2 FY27 revenue or profit estimate in the available information, so the reported results will be the first confirmed financial update for the September 2026 quarter.